Ferrous glycine sulfate

DB14501ApprovedSmall molecule

Ferrous glycine sulfate is an iron supplement indicated in the treatment of iron deficiency and iron deficiency anemia. A medication used to treat low levels of iron in the body.

Mechanism: Iron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
Curator reviewed
Primary indication: Used in preventing and treating iron-deficiency anemia.Curator reviewed · 1 structured indication
Formula / weight: C₄H₁₀FeN₂O₈S · 302.041 g/mol (avg)
Also known as: Ferrous glycine sulphate · Iron(II) glycine sulfate

Resolves to

Compound

UNII56PS9HY5XICAS14729-84-1ChEMBLCHEMBL3707208PubChem167159

Clinical / RWD

RxNorm105655ATCB03AA01

Structure

InChIKeyYJYOLOWXCPIBSY-UHFFFAOYSA-LSMILES[Fe++].NCC([O-])=O.NCC([O-])=O.OS(O)(=O)=O

Targets

P02786TFRCQ9GZT9EGLN1Q9BY41HDAC8Q9NZD4AHSPP69905HBA1Q16595FXNP02794FTH1P39748FEN1+5 more

What you can answer from here — as of April 02, 2025

13Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

6ContraindicationsEach with its own population and attribute set

19Marketed productsAcross 3 countries and 2 labellers

1ATC codeIncluding every combination product, plus 4 drug categories

14+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ferrous glycine sulfate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account